Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Cellular and Molecular Neuroscience,Pharmacology,Molecular Biology,Molecular Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00018-020-03459-1.pdf
Reference125 articles.
1. Siegel RL, Miller KD (2017) Cancer statistics, 2017. CA Cancer J Clin 67(1):7–30
2. Isaacsson Velho P, Antonarakis ES (2018) PD-1/PD-L1 pathway inhibitors in advanced prostate cancer. Expert Rev Clin Pharmacol 11(5):475–486
3. Harris E (2018) Immunotherapeutics for the treatment of prostate cancer: a patent landscape based on key therapeutic mechanisms of actions. Pharm Pat Anal 7(1):47–57
4. Vlachostergios PJ, Paddock M, Molina AM (2018) Molecular targeted therapies of prostate cancer. In: Precision molecular pathology of prostate cancer, Springer, New York, pp 523–546
5. Gulley JL, Borre M, Vogelzang NJ, Ng S, Agarwal N, Parker CC, Pook DW, Rathenborg P, Flaig TW, Carles J (2019) Phase III trial of PROSTVAC in asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer. J Clin Oncol 37(13):1051–1061
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting Dual Immune Checkpoints PD‐L1 and HLA‐G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer;Advanced Science;2024-09-05
2. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12
3. Regulatory and memory T lymphocytes infiltrating prostate tumors predict long term clinical outcomes;Frontiers in Immunology;2024-06-03
4. Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors;Journal of Medicinal Chemistry;2024-02-27
5. Immunosuppressive role of BDNF in therapy‐induced neuroendocrine prostate cancer;Molecular Oncology;2024-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3